San Francisco, 14 May 2025: The Report Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares), By End Use (Hospital, Emergency Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecast, 2025 - 2030
The global neurothrombectomy devices market size is expected to reach USD 1.1 billion by 2030, registering a CAGR of 6.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.
Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.
Increasing incidences of acute ischemic stroke on a global level is majorly driving the market. Furthermore, increased adoption of unhealthy lifestyles and increasing awareness of the disorder among the population is fueling the market for neurothrombectomy devices. Neurothrombectomy devices are critical in treating ischemic stroke, a commonly occurring phenomenon of stroke among older adults. Modern lifestyle, stress, and dietary habits have been observed to result in the risk of stroke among adults older than 40 years.
Stroke is the leading cause of disability among the elderly, with around 65.0% of patients requiring physical assistance/support post an episode of stroke. Approximately 15 million people worldwide are expected to suffer from stroke each year, according to WHO. Since the neurothrombectomy procedure improves functional outcomes and lowers the mortality rate in patients, it is the most preferred treatment for acute ischemic stroke. Thereby boosting market growth over the forecast period.
Request sample report of Neurothrombectomy Devices Market@ https://www.grandviewresearch.com/industry-analysis/neurothrombectomy-devices-market/request/rs1
Stroke is the most common cause of death, followed by heart and cancer diseases worldwide. For instance, according to WHO, in 2016, 15.2 million deaths of the 56.9 million deaths worldwide were due to stroke. Acute Ischemic Stroke (AIS) is the most common form of stroke, caused due to reduced blood supply to the brain, making brain cells die. For instance, according to the U.S. CDC, 87.0% of strokes are classified as ischemic strokes, with the U.S. being the most affected country According to Southwestern Medical Center, about 795,000 people in the U.S. suffer from a stroke every year. Furthermore, according to the National Center for Biotechnology Information (NCBI), strokes occur more commonly in women than men, especially in the elderly population (aged 55 to 65).
There are various initiatives undertaken by the government worldwide to prevent stroke. Some of the examples include the Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) program started by the U.S. CDC in three states-North Carolina, Massachusetts, and Arizona-to minimize the risk of stroke & heart diseases in women by promoting a heart-healthy lifestyle. These programs target uninsured women and low-income populations aged 40 to 64 in an attempt to spread awareness about heart diseases and other chronic conditions. From 2008 to 2013, nearly 91% of women who had strokes were offered effective care because of such awareness programs.
Moreover, the Global Stroke Bill of Rights campaign was started in 2014 by the World Stroke Organization for people suffering from stroke. This campaign helps patients avail effective care. In addition, with the help of Paul Coverdell National Acute Stroke Program, which started in 2005, CDC provides support and funding to healthcare departments of states to improve the quality of care for patients suffering from acute stroke disease. Since the initiation of this program, nearly 1 million stroke patients have been treated across 700 hospitals in the U.S. Thus, the abovementioned factors are expected to boost market growth.
Countries such as the U.S., UK, and Germany have witnessed a high incidence of hemorrhagic & ischemic stroke in recent years. According to the CDC, about 140,000 and 795,000 people in the U.S. die and suffer from stroke every year, respectively. In addition, the rising demand for minimally invasive procedures for treating neurovascular diseases further contributes to market growth in these countries. Similarly, the increase in mechanical thrombectomy procedures and the high adoption of technologically advanced products are major factors driving the market growth of German neurothrombectomy devices over the forecast period. For instance, as per an article published by BioMed Central Ltd in 2019, the rate of mechanical thrombectomy procedures has increased from 0.8% to 4.7% from 2010 to 2016. It was also reported that intravenous thrombolysis increased from 8.9% to 14.9% from 2010 to 2016. As intravenous thrombolysis and mechanical thrombectomy are major reasons for triggering acute ischemic stroke, increasing prevalence of these conditions is expected to boost the demand for neurothrombectomy devices, which is expected to drive the market.
Furthermore, the introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. Various other technologies are used to develop neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, in April 2019, Medtronic announced the launch of its fourth-generation Solitaire X revascularization device, designed for treating AIS. Furthermore, In May 2019, Vesalio received CE mark approval for NeVa-an advanced neurothrombectomy device featuring an optimized delivery system for efficient results. These devices expand on Drop Zone and Smart Maker technologies, introducing features such a
The global neurothrombectomy devices market size is expected to reach USD 1,051.3 million by 2028 according to a new study by Polaris Market Research.
The report “Neurothrombectomy Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares); By End-Use (Hospitals, Emergency Clinics, Ambulatory Surgical Centers), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global aging population, increasing prevalence of heart related diseases due to faulty and busy lifestyle, favorable government support and funding towards research and innovation, and product launches by the key market players in the neurothrombectomy devices industry.
Moreover, as per CDC, each year, 480,000 smokers die prematurely.
Request a sample this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/neurothrombectomy-devices-market/request-for-sample Developed countries like the U.S. and Canada have witnessed a high prevalence of ischemic heart-related disorders.
Similarly, as per the reports of the Stroke Report, in 2017, it was reported that around 400,000 people were suffering from long-term disability from heart stroke, and the number is expected to increase in the coming decade.
Global Facial Wipes Industry is projected to be valued at USD 3.16 Billion by 2025, registering a CAGR of 4.7% between 2019 and 2025.
The rising demand for convenience skincare products is driving the growth of the global facial wipes industry.
Increasing concerns related to skin problems and beauty have also propelled the growth of the industry.
Nevertheless, the demand for facial wipes made using natural and organic ingredients has been identified as a growth opportunity for facial wipes manufacturers.Industry USPWidespread availability of products specific to different skin types and concerns.Growth Opportunities in the IndustryDominance of wet facial wipes in the industry: The wet facial wipes segment dominated the global facial wipes industry in 2018 and is expected to remain dominant during the forecast period.
Such innovations are driving the growth of the segment.Increasing demand for organic facial wipes: Concerns regarding the environment and the harmful chemicals used in facial wipes have led to a rise in the demand for organic and naturally made facial wipes.
Vendors are, therefore, focused on enhancing their product portfolios by using biodegradable or plant-based fibers with less or no artificial chemicals.Performance facial wipes to be the fastest-growing segment: Performance facial wipes are used by consumers for specific purposes such as to treat acne, remove tan, UV protection, reduce the effects of aging, and other skin concerns.
Vsat MarketThe sudden challenges created by the ongoing COVID-19 are captured effectively to exhibit the long term growth projections in the MRFR report on Vsat Market.
The growth sectors of the Vsat Market are identified with precision for a better growth perspective.The global enterprise VSAT market is expected to reach 10,617.5 Million by 2024, exhibiting a CAGR of 8.8% during the forecast period (2018–2024).Competitive AnalysisThe prominent players that operate in the market are Hughes Network Systems LLC (US), Singtel (Singapore), Comtech Telecommunications Corporation (US), Gigasat Inc. (US), Skycaster LLC (US), Gilat Satellite Networks.
(Israel), VT iDirect (US), Newtec (Belgium), Viasat Inc (US), Global Eagle s(US), and Omniaccess (Spain).Segmental AnalysisThe global enterprise VSAT market has been segmented based on type, organization size, and region.Based on the type, the Enterprise VSAT market has been segmented into hardware and services.
The services segment is projected to grow with significant CAGR during the forecast period as it is largely implemented across industries.Based on organization size, the Enterprise VSAT market has been segmented into small and medium enterprises, and large enterprises.
Moreover, the presence of industry giants such as Newtec, Hughes Network Systems LLC, and Comtech Telecommunications Corp., VT iDirect, is one of the driving factors for the enterprise VSAT market in this region.Asia-Pacific has been segmented into China, India, Japan, South Korea, and South-East Asia.
According to the MRFR analysis, China is expected to gain the highest market share, followed by India, Japan, South-East Asia, and South Korea.
